Westside Investment Management, Inc.
Position in KZIA — Kazia Therapeutics Ltd
CIK 1538383
SANTA MONICA, CA
Position in KZIA
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$669,996
+$294,834 QoQ
Shares Held
47,585
-5.6% QoQ
Ownership
0.416%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#17
of 36 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in KZIA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Westside Investment Management, Inc. holds $2,010,311 across 23 Biotechnology names. KZIA ranks #1 (33.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KZIA |
Kazia Therapeutics Ltd
This page
|
47,585 | $669,996 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
6,140 | $334,875 | |
| 3 | LTRN |
Lantern Pharma Inc.
|
47,850 | $199,534 | |
| 4 | INMB |
Inmune Bio, Inc.
|
108,300 | $176,529 | |
| 5 | ANIX |
Anixa Biosciences Inc
|
43,000 | $120,400 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
181 | $112,860 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
179 | $88,914 | |
| 8 | ARGX |
Argenx SE
|
60 | $55,666 |
All Filings in KZIA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $669,996 | 47,585 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $375,162 | 50,425 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $212,728 | 30,875 | Shares | Sole | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||